Abstract
recently been established in Sheffield involving staff from the Sheffield Children’s NHS Foundation Trust and the Sheffield Teaching Hospitals NHS Foundation Trust. Children and adults with uveitis are managed using similar treatment strategies encompassing a combination of MTX, MMF and biologic treatments. We conducted a service evaluation to describe response to treatment in individuals receiving combination therapy: MTX and MMF. Here we report data from the paediatric service. Aims: To document the treatment pathway for children and young people with uveitis ultimately receiving triple immunosuppression therapy and to describe response to treatment in terms of disease activity and visual acuity. Methods: A key word search of a comprehensive ophthalmic electronic clinic letter storage system was conducted.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
